 |
|
||||||||
 |
|||||||||
|
|
|||||||||
|
|
||||||||
|
|||||||||
|
|
|||||||||
|
|
||||||||
 |
 |
 |
 |
 |
||
 |
 |
||||||||
|
|||||||||
|
|||||||||
|
The following preparations of recombinant proteins are in different phases of production technology development, pre-clinical and clinical trials:
PharmBiotek company also realizes development of different pharmaceutical forms of human interferon alpha-2b which are intended to release under the following trademarks: Lanoferon™, Alpharekin™, Neorekin™. |
|||||||||
